Invention Grant
US07985861B2 Piperidinyl derivatives as modulators of chemokine receptor activity
有权
哌啶基衍生物作为趋化因子受体活性的调节剂
- Patent Title: Piperidinyl derivatives as modulators of chemokine receptor activity
- Patent Title (中): 哌啶基衍生物作为趋化因子受体活性的调节剂
-
Application No.: US12505724Application Date: 2009-07-20
-
Publication No.: US07985861B2Publication Date: 2011-07-26
- Inventor: Percy H. Carter , Cullen L. Cavallaro , John V. Duncia , Daniel S. Gardner , John Hynes , Rui-Qin Liu , Joseph B. Santella , Dharmpal S. Dodd
- Applicant: Percy H. Carter , Cullen L. Cavallaro , John V. Duncia , Daniel S. Gardner , John Hynes , Rui-Qin Liu , Joseph B. Santella , Dharmpal S. Dodd
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Laurelee A. Duncan; Elliott Korsen; Terence Bogie
- Main IPC: C07D211/06
- IPC: C07D211/06 ; A61K31/535
Abstract:
The present application describes substituted piperidinyl modulators of MIP-1α or CCR-1 or stereoisomers or pharmaceutically acceptable salts thereof. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and transplant rejection using said modulators are disclosed.
Public/Granted literature
- US20090298833A1 PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Public/Granted day:2009-12-03
Information query
